These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23723643)

  • 1. Evaluation of Saptarangyadi Ghanavati in the management of Apathyanimittaja Prameha w.s.r. to type-2 diabetes mellitus.
    Singh KS; Chandola H; Kaur M; Ravishankar B
    Ayu; 2012 Jul; 33(3):368-73. PubMed ID: 23723643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic and antihyperglycemic activity of Saptarangyadi Ghanavati: An Ayurvedic compound formulation.
    Singh KS; Ashok BK; Kaur M; Ravishankar B; Chandola HM
    Ayu; 2014 Apr; 35(2):187-90. PubMed ID: 25558166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative study.
    Herath HMM; Weerarathna TP; Fonseka CL; Vidanagamage AS
    Diabetes Metab Syndr; 2017; 11(2):133-136. PubMed ID: 27746068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ayurvedic treatments for diabetes mellitus.
    Sridharan K; Mohan R; Ramaratnam S; Panneerselvam D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008288. PubMed ID: 22161426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of dipeptidyl peptidase-IV (DPP-IV) in Indian type-2 diabetic population.
    Venkatesham A; Srinivas M; Krishna DR; Narayana P
    J Assoc Physicians India; 2009 Sep; 57():627-30. PubMed ID: 20213998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus. A model of medicine-based evidence.
    Scorpiglione N; Belfiglio M; Carinci F; Cavaliere D; De Curtis A; Franciosi M; Mari E; Sacco M; Tognoni G; Nicolucci A
    Eur J Clin Pharmacol; 1999 Jun; 55(4):239-49. PubMed ID: 10424314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
    Owens DR
    Diabet Med; 1998; 15 Suppl 4():S28-36. PubMed ID: 9868989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the serum insulin and the serum uric Acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus.
    Gill A; Kukreja S; Malhotra N; Chhabra N
    J Clin Diagn Res; 2013 Jul; 7(7):1295-7. PubMed ID: 23998049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus.
    Aughsteen AA; Abu-Umair MS; Mahmoud SA
    Saudi Med J; 2005 Jan; 26(1):73-7. PubMed ID: 15756357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a standardized Ayurvedic formulation on diabetes control in newly diagnosed Type-2 diabetics; a randomized active controlled clinical study.
    Awasthi H; Nath R; Usman K; Mani D; Khattri S; Nischal A; Singh M; Sawlani KK
    Complement Ther Med; 2015 Aug; 23(4):555-61. PubMed ID: 26275648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on Diastolic Dysfunction in Newly Diagnosed Type 2 Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin (HbA1C).
    Chaudhary AK; Aneja GK; Shukla S; Razi SM
    J Clin Diagn Res; 2015 Aug; 9(8):OC20-2. PubMed ID: 26435985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.
    McSorley PT; Bell PM; Jacobsen LV; Kristensen A; Lindholm A
    Clin Ther; 2002 Apr; 24(4):530-9. PubMed ID: 12017398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of
    Yadav U; Bhatted SK
    Ayu; 2021; 42(1):30-34. PubMed ID: 36743277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions.
    Trovati M; Ponziani MC; Massucco P; Anfossi G; Mularoni EM; Burzacca S; Tassone F; Perna P; Traversa M; Cavalot F
    Eur J Clin Invest; 2002 Mar; 32(3):179-86. PubMed ID: 11895469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Serum TNF-
    Alzamil H
    J Obes; 2020; 2020():5076858. PubMed ID: 32089876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Complications and Clinical Audit of Management of Type 2 Diabetes Mellitus: A Prospective Hospital Based Study.
    Kulshrestha M; Seth S; Tripathi A; Seth A; Kumar A
    J Clin Diagn Res; 2015 Nov; 9(11):OC25-8. PubMed ID: 26673042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Body Mass Index, Glycemic Control, and Hypoglycemic Drugs on Serum Uric Acid Levels in Type 2 Diabetic Patients.
    Hussain A; Latiwesh OB; Ali F; Younis MYG; Alammari JA
    Cureus; 2018 Aug; 10(8):e3158. PubMed ID: 30349765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of diabetic management modes on diabetic nephropathy: a prospective study].
    Li J; Huang B; Wang S; Ji X; Yin J; Yang N; Zhai J; Kang W; Ma X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1497-1500. PubMed ID: 32029036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.